7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lim WH et al. | Downregulation of Wnt causes root resorption. | 2014 | Am J Orthod Dentofacial Orthop | pmid:25172256 |
| Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
| Zhang X et al. | Ultrastructural characterization of the implant interface response to loading. | 2014 | J. Dent. Res. | pmid:24389808 |
| Lv Z et al. | Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. | 2014 | Oncol. Rep. | pmid:24337584 |
| Bandeira F et al. | Bone markers and osteoporosis therapy. | 2014 | Arq Bras Endocrinol Metabol | pmid:25166041 |
| Kim YH et al. | Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. | 2014 | Biomaterials | pmid:24125774 |
| Zhao JJ et al. | Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. | 2014 | Genet. Mol. Res. | pmid:24737508 |
| Yoo YM et al. | Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. | 2014 | Int J Mol Sci | pmid:24717410 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Liu S et al. | Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. | 2013 Oct-Dec | Hormones (Athens) | pmid:24457406 |
| Chiang PH et al. | Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. | 2013 Oct-Dec | J Cancer Res Ther | pmid:24518712 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Zamora PO et al. | Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. | 2013 Mar-Apr | Int. J. Toxicol. | pmid:23422080 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Glintborg D et al. | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23211475 |
| Nanjundaiah SM et al. | Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. | 2013 Jan-Mar | Int J Immunopathol Pharmacol | pmid:23527707 |
| Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
| Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
| Scholtysek C et al. | PPARβ/δ governs Wnt signaling and bone turnover. | 2013 | Nat. Med. | pmid:23542786 |
| Wu X et al. | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. | 2013 | Eur. J. Med. Res. | pmid:23731710 |
| Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
| Løgstrup BB et al. | Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. | 2013 | Coron. Artery Dis. | pmid:23777975 |
| Rozas Moreno P et al. | Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? | 2013 | J. Endocrinol. Invest. | pmid:22391059 |
| Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
| Pichler K et al. | Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. | 2013 | Connect. Tissue Res. | pmid:23941205 |
| Bezerra JP et al. | Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. | 2013 | J. Periodontol. | pmid:22873654 |
| Yabumoto T et al. | Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23992809 |
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Anastasilakis AD et al. | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23788684 |
| Wei CC et al. | Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. | 2013 | BMC Complement Altern Med | pmid:23870279 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Xu F et al. | Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. | 2013 | Mol Med Rep | pmid:23835909 |
| Di Bartolo BA et al. | TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. | 2013 | PLoS ONE | pmid:24040204 |
| Weng CH et al. | [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23596799 |
| Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
| Zong ming W et al. | Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load. | 2013 | Biomed Eng Online | pmid:23597232 |
| Liu CG et al. | [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:24517065 |
| Wang Q et al. | [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized]. | 2013 | Zhongguo Gu Shang | pmid:24605748 |
| Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
| Lazzerini PE et al. | Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. | 2013 | Joint Bone Spine | pmid:22999910 |
| Matsuo K | [Osteoimmunologic regulation of aging]. | 2013 | Clin Calcium | pmid:23268303 |
| Feng ZY et al. | Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. | 2013 | Mol Med Rep | pmid:24126801 |
| Wang X et al. | Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. | 2013 | Chin. J. Traumatol. | pmid:24103822 |
| Chen X et al. | Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. | 2013 | Food Chem. Toxicol. | pmid:23954550 |
| Saki F et al. | Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. | 2013 | J. Bone Miner. Res. | pmid:23322328 |
| Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
| Malik P et al. | Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. | 2013 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:23380173 |
| Grant M et al. | Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement. | 2013 | Eur J Orthod | pmid:22987319 |
| Deng YH et al. | The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. | 2013 | Endocrine | pmid:22798246 |